Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Morishima

Showing results (301-310 of 334) with videos related to

Pageof 34
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2013
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell TransplantationS Nishiwaki, K Miyamura, K Ohashi, et al.
Blood Cancer Journal|December 6, 2014
Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donorJ Kanda, S Fuji, S Kato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1979
[Treatment of infection in the patients of acute leukemia with sulfamethoxazole-trimethoprim (author's transl)]K Ezaki, R Ohno, T Kamiya, et al.
Bone Marrow Transplantation|September 15, 2015
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantationY Arai, J Kanda, H Nakasone, et al.
Blood|October 26, 2000
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotypeR Suzuki, Y Kagami, K Takeuchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II studyT Igarashi, Y Kobayashi, M Ogura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1978
[Treatment of therapy-resistant acute non-lymphocytic leukemia with PADOC (author's transl)]H Yoshikawa, T Uetani, F Sako, et al.
Pathology International|March 8, 2002
Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 casesY Yatabe, R Suzuki, Y Matsuno, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase)M Matsuki, F Yamashita, A Ishida-Yamamoto, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|November 1, 1982
[Allogeneic bone marrow transplantation in 14 cases of leukemia]H Yamada, H Yamaguchi, Y Morishima, et al.
Pageof 34

Showing results (301-310 of 334) with videos related to

Sort By:
Pageof 34
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2013
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell TransplantationS Nishiwaki, K Miyamura, K Ohashi, et al.
Blood Cancer Journal|December 6, 2014
Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donorJ Kanda, S Fuji, S Kato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1979
[Treatment of infection in the patients of acute leukemia with sulfamethoxazole-trimethoprim (author's transl)]K Ezaki, R Ohno, T Kamiya, et al.
Bone Marrow Transplantation|September 15, 2015
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantationY Arai, J Kanda, H Nakasone, et al.
Blood|October 26, 2000
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotypeR Suzuki, Y Kagami, K Takeuchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II studyT Igarashi, Y Kobayashi, M Ogura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1978
[Treatment of therapy-resistant acute non-lymphocytic leukemia with PADOC (author's transl)]H Yoshikawa, T Uetani, F Sako, et al.
Pathology International|March 8, 2002
Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 casesY Yatabe, R Suzuki, Y Matsuno, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase)M Matsuki, F Yamashita, A Ishida-Yamamoto, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|November 1, 1982
[Allogeneic bone marrow transplantation in 14 cases of leukemia]H Yamada, H Yamaguchi, Y Morishima, et al.
Pageof 34